Y

Y-mAbs Therapeutics, Inc.

119 employees

YmAbs is a clinical stage biopharmaceutical company that discovers and develops innovative treatments for cancer patients.

Basic info

Industry

biotechnology research

Sectors

Biotechnology
Health Care
Therapeutics
Medical

Date founded

2015

Funding rounds raised

Total raised

$30M

from 1 investors over 1 rounds

Y

Y-mAbs Therapeutics, Inc. raised $30M on November 29, 2017

Investors: Sofinnova Ventures, Russia technology fund

FAQ